LH 10-Q report for 2026-03-31
Labcorp (LH) filed its Form 10‑Q for the quarter ended March 31, 2026. The report contains unaudited condensed consolidated financial statements and disclosures for the period, including balance sheet, statement of operations, cash flows, and notes. Key reported metrics: revenues $3,537.6M; net earnings $278.0M; diluted EPS $3.35; cash and cash equivalents $981.1M; total assets $19,087.1M; long‑term debt $5,833.7M. The filing confirms 82.0M common shares outstanding as of May 1, 2026.
Linked assets
Primary ticker: LH (New York Stock Exchange). The 10‑Q provides quarter‑to‑quarter financials, capital‑structure detail, and cash‑flow activity (including a $750.0M term‑loan draw and $98.0M share repurchase in the quarter).
Labcorp Holdings Inc. (LH) Form 10‑Q for quarter ended March 31, 2026. Key reported results: Revenues $3,537.6M; Gross profit $1,013.8M; Operating income $380.8M; Net earnings $278.0M; Diluted EPS $3.35; Cash and cash equivalents $981.1M; Total assets $19,087.1M; Long‑term debt $5,833.7M. Shares outstanding ~82.0M as of May 1, 2026.
The filing supplied the unaudited condensed consolidated financial statements and accompanying notes for the quarter. It documents quarter‑over‑quarter performance and capital‑structure activity (including a $750.0M term‑loan draw and $98.0M share repurchase). This is a primary, authoritative source for LH’s reported quarterly results and balance sheet metrics, but actionability depends on analysis of MD&A, risk factors, and forward guidance that appear elsewhere in the filing.
Source proof
Source proof: Strong source proof | 1 directional asset | 1 supporting author | headline-like title review
Source: Labcorp Holdings Inc. Form 10‑Q for the quarterly period ended March 31, 2026. The filing includes consolidated balance sheets, statements of operations, comprehensive earnings, changes in shareholders’ equity, cash flows, and notes. Exact figures and line items are taken from the company’s unaudited condensed consolidated financial statements contained in the 10‑Q.
This excerpt is only the cover page/header of Sleep Number’s Form 10-Q for the quarter ended April 4, 2026. It contains filing metadata (issuer, ticker, exchange, address) but no financial statements, MD&A, guidance, risks, or operational commentary. As a result, it is not directly actionable for trading beyond confirming the filing exists.
The provided excerpt is only the cover/filing header of SoundHound AI, Inc.’s 10‑Q for the quarter ended 2026‑03‑31. It contains listing/security identifiers (SOUN, SOUNW) but no financial statements, MD&A, guidance, risk updates, liquidity details, or material events. As a result, there is insufficient information to form high-confidence, actionable bullish/bearish theses beyond generic “company filed its 10‑Q” metadata.
The provided excerpt is only the boilerplate cover/filing-status section of Teucrium Commodity Trust’s Form 10‑Q for period ended 2026‑03‑31, with no portfolio holdings, performance, risk, or material updates included. As-is, it contains no actionable investment information beyond confirming the existence of the filing and the issuer/ticker identity (WEAT).
This excerpt is essentially the cover page of Archer Aviation’s Form 10‑Q for the quarter ended 2026‑03‑31 (issuer identity, exchange listing, and securities outstanding). It contains no operating/financial results, guidance, liquidity details, backlog, or risk-factor updates—so it is minimally actionable for trading beyond basic security identifiers and a generic dilution/optionality consideration from warrants.
This excerpt is essentially the cover page of CleanSpark, Inc.’s Form 10-Q for the quarter ended March 31, 2026. It contains identifiers (CIK/file no.), listing venue, and security descriptions (common stock and redeemable warrants with specific exercise terms), but no operating/financial results, guidance, risks, or MD&A detail. Actionability is therefore limited to capital-structure/dilution considerations around the listed warrant.
This excerpt of AST SpaceMobile’s 10‑Q is largely SEC cover-page/boilerplate (registrant info, exchange listing, filing compliance) and contains no financial results, guidance, liquidity, risk-factor updates, or operating metrics. As provided, it does not create a clear tradable catalyst beyond confirming continued reporting/listing status.
This excerpt only includes the cover page of Super Micro Computer, Inc.’s Form 10‑Q for the quarter ended March 31, 2026. It confirms the filing, issuer identity, listing (Nasdaq), and ticker (SMCI), but contains no financial results, guidance, risks, or MD&A content to support a directional investment view.
The provided text is only the cover/header portion of AbCellera Biologics Inc.’s Form 10‑Q for the quarter ended March 31, 2026 (identifying info, exchange listing, filing status). It contains no financial statements, guidance, risk updates, material events, MD&A, cash runway, pipeline/program updates, or disclosures that would support a differentiated trading view.
Supporting authors
Author: 1 source document (Labcorp 10‑Q). Related filings from other issuers are listed as context but do not affect Labcorp’s financial disclosures.
Unlock full thesis monitoring
For trading decisions, review the full 10‑Q for Management’s Discussion & Analysis, risk factors, liquidity disclosures, and footnote detail. Use the filing to verify reported metrics and any material subsequent events before adjusting positions.